Showing results (361-370 of 511) with videos related to

Sort By:
Pageof 52
Veterinary Ophthalmology|February 29, 2024
Feline distichiasis treated with cryoepilation: A retrospective study of 15 cats (27 eyes)B D Reynolds, M J Annear, K A Caruso, et al.
Inflammatory Bowel Diseases|December 27, 2021
Predictors of Sustained Response With Tofacitinib Therapy in Patients With Ulcerative ColitisWilliam J Sandborn, Alessandro Armuzzi, Giuseppina Liguori, et al.
BMJ Open Gastroenterology|July 14, 2018
Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)Christopher Sj Probert, Shaji Sebastian, Daniel R Gaya, et al.
Nature Structural Biology|July 6, 2000
Conformation of the myosin motor during force generation in skeletal muscleM Irving, G Piazzesi, L Lucii, et al.
Veterinary Ophthalmology|December 13, 2021
Use of subdermal hyaluronic acid injections and a free labial mucocutaneous graft for the repair of feline eyelid agenesisKelly A Caruso, Benjamin D Reynolds, Cameron J Whittaker, et al.
Scottish Medical Journal|August 1, 1996
General practice blood pressure recording in Scotland: variations in the classification of hypertensionB S Henderson, M W Taylor, R M Milne, et al.
Clinical Drug Investigation|April 2, 2023
Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical TrialGeert D'Haens, Walter Reinisch, Stefan Schreiber, et al.
American Journal of Preventive Medicine|February 17, 2018
Sexual Orientation Discordance and Nonfatal Suicidal Behaviors in U.S. High School StudentsFrancis B Annor, Heather B Clayton, Leah K Gilbert, et al.
Frontline Gastroenterology|August 26, 2017
Utilisation of anti-TNF levels in a UK tertiary IBD centreE L Johnston, B D Warner, J L Digby-Bell, et al.
Medicine|March 1, 2019
A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE studyFraser Cummings, Daniel R Gaya, Scott Levison, et al.
Pageof 52